XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 164 filers reported holding XENON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62,443,045 | -11.3% | 1,827,958 | 0.0% | 1.68% | -14.2% |
| Q2 2023 | $70,376,383 | +7.6% | 1,827,958 | 0.0% | 1.96% | -18.0% |
| Q1 2023 | $65,422,617 | +30.5% | 1,827,958 | +43.8% | 2.39% | +13.1% |
| Q4 2022 | $50,125,111 | +54.1% | 1,271,243 | +41.1% | 2.12% | +57.4% |
| Q3 2022 | $32,530,000 | -33.1% | 901,095 | -43.6% | 1.34% | -42.8% |
| Q2 2022 | $48,610,000 | -0.5% | 1,597,966 | 0.0% | 2.35% | +20.2% |
| Q1 2022 | $48,850,000 | -52.5% | 1,597,966 | -51.4% | 1.95% | -47.6% |
| Q4 2021 | $102,765,000 | +327.9% | 3,289,540 | +109.3% | 3.73% | +298.1% |
| Q3 2021 | $24,017,000 | -17.9% | 1,571,778 | 0.0% | 0.94% | -14.6% |
| Q2 2021 | $29,267,000 | -53.0% | 1,571,778 | -54.9% | 1.10% | -53.1% |
| Q1 2021 | $62,324,000 | +15.8% | 3,481,778 | -0.5% | 2.34% | +10.4% |
| Q4 2020 | $53,820,000 | +38.9% | 3,499,346 | 0.0% | 2.12% | +0.3% |
| Q3 2020 | $38,738,000 | -12.2% | 3,499,346 | -0.5% | 2.11% | -22.4% |
| Q2 2020 | $44,101,000 | +45.4% | 3,516,851 | +31.5% | 2.72% | -3.8% |
| Q1 2020 | $30,327,000 | +18.7% | 2,674,338 | +37.2% | 2.83% | +45.9% |
| Q4 2019 | $25,552,000 | +62.8% | 1,949,075 | +11.9% | 1.94% | +17.5% |
| Q3 2019 | $15,692,000 | -8.6% | 1,741,600 | 0.0% | 1.65% | -12.1% |
| Q2 2019 | $17,172,000 | -5.5% | 1,741,600 | -2.6% | 1.88% | -7.9% |
| Q1 2019 | $18,174,000 | +61.0% | 1,788,774 | 0.0% | 2.04% | +38.0% |
| Q4 2018 | $11,287,000 | -26.6% | 1,788,774 | +53.5% | 1.48% | +9.1% |
| Q3 2018 | $15,385,000 | +132.0% | 1,165,553 | +61.7% | 1.35% | +109.0% |
| Q2 2018 | $6,632,000 | +87.8% | 720,830 | 0.0% | 0.65% | +80.7% |
| Q1 2018 | $3,532,000 | -65.2% | 720,830 | -79.9% | 0.36% | -70.7% |
| Q4 2017 | $10,138,000 | -4.2% | 3,588,830 | 0.0% | 1.22% | -9.2% |
| Q3 2017 | $10,587,000 | -4.5% | 3,588,830 | +2.0% | 1.35% | -21.8% |
| Q2 2017 | $11,084,000 | -6.1% | 3,518,830 | +19.3% | 1.72% | -14.3% |
| Q1 2017 | $11,799,000 | -49.7% | 2,949,794 | -3.1% | 2.01% | -57.4% |
| Q4 2016 | $23,437,000 | -6.9% | 3,043,805 | -2.1% | 4.71% | -0.8% |
| Q3 2016 | $25,182,000 | +139.6% | 3,108,905 | +75.1% | 4.74% | +111.9% |
| Q2 2016 | $10,511,000 | -15.3% | 1,775,572 | 0.0% | 2.24% | -27.1% |
| Q1 2016 | $12,411,000 | +37.1% | 1,775,572 | +57.7% | 3.07% | +99.2% |
| Q4 2015 | $9,050,000 | +5.8% | 1,125,572 | +8.7% | 1.54% | -10.8% |
| Q3 2015 | $8,554,000 | +9.3% | 1,035,572 | +52.6% | 1.73% | +25.1% |
| Q2 2015 | $7,826,000 | +18.6% | 678,764 | +73.4% | 1.38% | +0.1% |
| Q1 2015 | $6,601,000 | -45.9% | 391,424 | -36.7% | 1.38% | -41.9% |
| Q4 2014 | $12,210,000 | – | 618,224 | – | 2.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |